BSX
Boston Scientific Corporation · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +4.3% ·
aandelenstroom +2.7% ·
netto nieuwe posities +4.2%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 182 | -1 | 1.07B | $45.95B | +3 | −3 |
| Q1 2026 | 185 | -2 | 1.08B | $67.75B | +2 | −5 |
| Q4 2025 | 186 | +1 | 1.13B | $107.60B | +2 | — |
| Q3 2025 | 28 | 0 | 719.46M | $70.18B | — | −1 |
| Q2 2025 | 26 | -1 | 668.30M | $71.71B | — | −1 |
| Q1 2025 | 24 | +1 | 275.71M | $27.75B | +1 | — |
| Q4 2024 | 23 | -1 | 268.54M | $23.93B | — | −1 |
| Q3 2024 | 23 | +2 | 200.54M | $16.75B | +2 | — |
| Q2 2024 | 21 | — | 195.84M | $15.04B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 64.48M | +0.8% | $6.50B | 0.3% | ▲ Add | 2 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 36.50M | -1.2% | $3.68B | 3.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 33.20M | -8.2% | $3.35B | 0.6% | ▼ Trim | 4 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (passief) | 31.80M | +3.8% | $3.20B | 0.3% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Capital World Investors ✦ | 28.56M | +2.4% | $2.88B | 0.5% | ▲ Add | 4 | SEC ↗ |
| 6 | Norges Bank ✦ (passief) | 19.97M | +1.2% | $2.01B | 0.3% | ▲ Add | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 10.61M | +18.6% | $1.07B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 7.95M | -10.3% | $801.81M | 1.1% | ▼ Trim | 4 | SEC ↗ ×4 |
| 9 | Millennium Management ✦ | 8.34M | -8.6% | $791.32M | 0.8% | ▼ Trim | 4 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 6.77M | +16.6% | $682.51M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 6.75M | +20.8% | $681.41M | 0.6% | ▲ Add | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 5.43M | +10.2% | $548.14M | 0.5% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | D. E. Shaw & Co. ✦ | 3.84M | +402.8% | $387.29M | 0.5% | ▲ Add | 4 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 2.59M | -1.1% | $261.49M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 2.44M | +229.0% | $246.22M | 0.6% | ▲ Add | 4 | SEC ↗ |
| 16 | Viking Global Investors ✦ | 2.38M | +9.4% | $239.77M | 0.8% | ▲ Add | 3 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 1.88M | -16.3% | $189.71M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 1.16M | +26.7% | $114.43M | 0.1% | ▲ Add | 4 | SEC ↗ ×6 |
| 19 | Renaissance Technologies ✦ | 651.55K | Nieuw | $65.73M | 0.1% | New | 1 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 126.58K | -2.1% | $12.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 100.00K | 0.0% | $10.09M | 0.3% | Held | 4 | SEC ↗ |
| 22 | Dodge & Cox ✦ | 91.69K | -3.3% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 63.95K | -60.7% | $6.45M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 34.97K | +206.0% | $3.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $65.73M | 0.1% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,653 houders, 1.31B aandelen, $78.98B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 2.04K aand @ 49.22 · $100,408
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie